Jill C. Milne's most recent trade in Astria Therapeutics Inc was a trade of 761,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 21, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Astria Therapeutics Inc | Jill C. Milne | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2025 | 761,000 | 761,000 | - | - | Stock Option (Right to Buy) | |
| Astria Therapeutics Inc | Milne C. Jill | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 534,600 | 534,600 | - | - | Stock Option (Right to Buy) | |
| Astria Therapeutics Inc | Jill C. Milne | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2023 | 275,000 | 275,000 | - | - | Stock Option (Right to Buy) | |
| Astria Therapeutics Inc | Jill C. Milne | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 195,000 | 195,000 | - | - | Stock Option (right to buy) | |
| Astria Therapeutics Inc | Jill C. Milne | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 1,400,000 | 1,400,000 | - | - | Stock Option (right to buy) |